Analystreport

PTC Therapeutics (PTCT) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $108.00 price target on the stock.

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com